Related Experiment Video
Updated: Dec 18, 2025

Subcutaneous Infection of Methicillin Resistant Staphylococcus Aureus MRSA
Published on: February 9, 2011
Impact of a Best Practice Advisory for Pediatric Patients With Staphylococcus aureus Bacteremia
Elizabeth C Lloyd1, Emily T Martin2, Nicholas Dillman3
1Division of Pediatric Infectious Diseases, University of Michigan, Ann Arbor, Michigan.
Insights
An electronic medical record system improved antibiotic therapy for Staphylococcus aureus bacteremia in children. This system led to faster treatment, especially for methicillin-sensitive S. aureus infections.
Area of Science:
- Pediatric Infectious Diseases
- Health Informatics
- Antimicrobial Stewardship
Background:
- Staphylococcus aureus bacteremia (SAB) requires prompt Infectious Diseases (ID) consultation and appropriate antibiotic therapy for optimal patient outcomes.
- Strategies to enhance adherence to these critical care pathways in pediatric populations remain under-explored.
Purpose of the Study:
- To evaluate the effectiveness of an electronic medical record (EMR)-based best practice advisory (BPA) system designed to improve ID consultation and optimal antibiotic selection for pediatric SAB.
- To assess the impact of the BPA on key clinical outcomes, including time to appropriate therapy and patient mortality.
Main Methods:
- A quasi-experimental study design was employed, comparing pediatric patients with SAB before and after the implementation of an EMR-based BPA.
- The BPA utilized rapid mecA gene detection to recommend ID consultation and optimal antibiotic therapy.
- Interrupted time series (ITS) analysis and Cox regression were used to evaluate changes in consultation rates and time to optimal therapy.
Main Results:
- The implementation of the EMR-based BPA was associated with a significant reduction in the median time to optimal antibiotic therapy, decreasing from 26.1 to 5.5 hours.
- This acceleration in optimal therapy was particularly pronounced in patients with methicillin-sensitive S. aureus (MSSA), with a median time reduction from 42.2 to 10.8 hours.
- While ID consultation rates increased throughout the study, the BPA did not demonstrate a statistically significant impact on consultation frequency due to pre-existing positive trends.
Conclusions:
- An EMR-based BPA effectively expedited the delivery of optimal antibiotic therapy for pediatric patients diagnosed with SAB.
- The system demonstrated particular efficacy in accelerating treatment for MSSA infections.
- The BPA's impact on ID consultation rates was less pronounced, likely due to concurrent improvements in care practices.
Background:
Infectious diseases (ID) consultation and optimal antibiotic therapy improve outcomes in Staphylococcus aureus bacteremia (SAB). Data on strategies to improve adherence to these practices in children are limited.
Methods:
This was a quasi-experimental study evaluating the impact of an electronic medical record (EMR)-based best practice advisory (BPA) for SAB, recommending ID consult and optimal antibiotic therapy based on rapid mecA gene detection. Inpatients < 21 years old with SAB before (January 2015-July 2017) and after (August 2017-December 2018) BPA implementation were included. Primary outcome was receipt of ID consult. Secondary outcomes included receipt of optimal therapy, time to ID consult and optimal therapy, recurrent SAB, and 30-day all-cause mortality. ID consultation rates pre- and postimplementation were compared using interrupted time series (ITS) analysis. Hazard ratios (HRs) and 95% confidence intervals (CIs) for time to optimal therapy were calculated using Cox regression.
Results:
We included 99 SAB episodes (70 preintervention, 29 postintervention). Preintervention, 48 (68.6%) patients received an ID consult compared to 27 (93.1%) postintervention, but this was not statistically significant on ITS analysis due to a preexisting trend of increasing consultation. Median hours to optimal therapy decreased from 26.1 to 5.5 (P = .03), most notably in patients with methicillin-sensitive S. aureus (MSSA) (42.2 to 10.8; P < .01). On Cox regression, BPA implementation was associated with faster time to optimal therapy (HR, 3.22 [95% CI, 1.04-10.01]).
Conclusions:
Implementation of an EMR-based BPA for SAB resulted in faster time to optimal antibiotic therapy, particularly for patients with MSSA. ID consultation increased throughout the study period and was not significantly impacted by the BPA.
More Related Videos
09:26Antibiotic Efficacy Testing in an Ex vivo Model of Pseudomonas aeruginosa and Staphylococcus aureus Biofilms in the Cystic Fibrosis Lung
Published on: January 22, 2021
08:32Development and Assessment of Intracellular Infection Models for Staphylococcus aureus
Published on: January 17, 2025
Related Concept Videos
Healthcare Associated Infections II: Preventive Measures
The best practices for preventing healthcare-associated infections include hand hygiene, patient risk...
Pharmacokinetics in Pediatric Patients: Drug Excretion
Standard Precaution
Hand hygiene is the most crucial means to prevent the transmission of disease. Employers are legally required to provide their workers with personal protective equipment (PPE) to minimize exposure or contact with...
Acute Pyelonephritis II: Diagnostic Studies and Management
Asepsis
Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption